Tarsus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.

About TARS

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. 

CEO
Bobak Azamian
CEOBobak Azamian
Employees
370
Employees370
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2017
Founded2017
Employees
370
Employees370

TARS Key Statistics

Market cap
3.09B
Market cap3.09B
Price-Earnings ratio
-45.08
Price-Earnings ratio-45.08
Dividend yield
Dividend yield
Average volume
424.73K
Average volume424.73K
High today
High today
Low today
Low today
Open price
$72.72
Open price$72.72
Volume
0.00
Volume0.00
52 Week high
$85.25
52 Week high$85.25
52 Week low
$38.51
52 Week low$38.51

Stock Snapshot

As of today, Tarsus Pharmaceuticals(TARS) shares are valued at $72.56. The company's market cap stands at 3.09B, with a P/E ratio of -45.08.

On 2026-04-13, Tarsus Pharmaceuticals(TARS) stock opened at $72.72, reached a high of —, and a low of —.

Tarsus Pharmaceuticals(TARS) shares are trading with a volume of 0, against a daily average of 424.73K.

During the past year, Tarsus Pharmaceuticals(TARS) stock moved between $38.51 at its lowest and $85.25 at its peak.

During the past year, Tarsus Pharmaceuticals(TARS) stock moved between $38.51 at its lowest and $85.25 at its peak.

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own TARS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.